Nationwide Fund Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-22,092
| Closed | -$90K | – | 2987 |
|
|
2017
Q3 | $90K | Buy |
22,092
+2,956
| +15% | +$12K | ﹤0.01% | 2942 |
|
|
2017
Q2 | $71K | Buy |
+19,136
| New | +$71K | ﹤0.01% | 3009 |
|
|
2016
Q2 | – | Sell |
-10,169
| Closed | -$77K | – | 3349 |
|
|
2016
Q1 | $77K | Hold |
10,169
| – | – | ﹤0.01% | 2896 |
|
|
2015
Q4 | $135K | Sell |
10,169
-422
| -4% | -$5.6K | ﹤0.01% | 2733 |
|
|
2015
Q3 | $174K | Sell |
10,591
-505
| -5% | -$8.3K | ﹤0.01% | 2641 |
|
|
2015
Q2 | $249K | Buy |
11,096
+454
| +4% | +$10.2K | ﹤0.01% | 2588 |
|
|
2015
Q1 | $104K | Buy |
10,642
+517
| +5% | +$5.05K | ﹤0.01% | 2950 |
|
|
2014
Q4 | $115K | Buy |
10,125
+865
| +9% | +$9.83K | ﹤0.01% | 2873 |
|
|
2014
Q3 | $107K | Buy |
9,260
+459
| +5% | +$5.3K | ﹤0.01% | 2968 |
|
|
2014
Q2 | $171K | Buy |
+8,801
| New | +$171K | ﹤0.01% | 2826 |
|
|
2013
Q3 | – | Sell |
-4,233
| Closed | -$40K | – | 3302 |
|
|
2013
Q2 | $40K | Buy |
+4,233
| New | +$40K | ﹤0.01% | 2998 |
|